Skip to main content
. 2018 Mar 28;92(8):e01957-17. doi: 10.1128/JVI.01957-17

FIG 5.

FIG 5

Heterologous NAbs induced by monovalent and multivalent regimens. The midpoint NAb titers (ID50) against tier 1A viruses SF162 (A) and MW965.26 (B) as determined using TZM-bl assay are plotted, while both data sets are combined in panel C. (D) Heterologous NAb titers (ID50) against 16 heterologous tier 2 viruses are shown. Individual ID50 values are reported in Table S1 in the supplemental material.